Practical Aproach to Variceal Gastrointestinal Bleeding – Association of Polish Surgeons Guidelines

• Authors: Grzegorz Wallner , Michał Solecki , Andrzej Dąbrowski , Grzegorz Ćwik , Andrzej Dąbrowski , Andrzej Matyja , Paweł Lampe , Adam Dziki
• Languages of publication: EN
• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2015
• Volume: 86
• Issue: 5
• Pages: 248-256

Dates

published

1 - 5 - 2014

online

1 - 7 - 2014

received

28 - 4 - 2014

References

• 1. Gralnek IM, Barkun AN, Bardou M: Management of acute bleeding from a peptic ulcer. N Engl J Med 2008 Aug 28; 359(9): 928-37.
• 2. Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139-48.[PubMed]
• 3. Lanas A: Editorial: Upper GI bleeding-associated mortality: chalanges to improving a resistant outcome. Am J Gastroenterol 2010; 105: 90-92.[PubMed][Crossref]
• 4. Petruff CA, Chora S: Classification of portal hypertension. W: Handbook of liver disease. Friedman LS, Keeffe EB (red.). Philadelphia, Churchill Livingstone 2004; 264.
• 5. World Gastroenterology Organisation practice guideline: esophageal varices. http: //www.guideline. gov/content.aspx?id=13000.
• 6. Calès P, Pascal JP: Natural history of esophageal varices in cirrhosis (from origin to rupture). Gastroenterol Clin Biol 1988 Mar; Vol. 12 (3): 245-54.[PubMed]
• 7. Wróblewski E, Dąbrowski A: Zasady leczenia krwawień z żylaków przełyku. Przegl Gastroenterol 2010; 5 (3): 123-44.
• 8. Merkel C, Marin R, Angeli P et al.: A placebocontrolled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004 Aug; Vol. 127 (2): 476-84.[Crossref]
• 9. de Franchis R: BavenoV Faculty. Revising consensus in portal hypertension: report of the BavenoV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010 Oct; Vol. 53 (4): 762-68.[Crossref]
• 10. D’Amico G, Pagliaro L, Bosch J: Pharmacological treatment of portal hypertension: an evidence- based approach. Semin Liver Dis 1999; Vol. 19 (4): 475-505.[Crossref][PubMed]
• 11. García-Pagán JC, Morillas R, Bañares R et al.: Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003 Jun; Vol. 37 (6): 1260-66.[Crossref]
• 12. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC: Portal hypertension and gastrointestinal bleeding. Semin Liver Dis 2008 Feb; Vol. 28 (1): 3-25.[PubMed][Crossref][WoS]
• 13. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG: The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48(Suppl. 1): S68-92.[Crossref][WoS]
• 14. Banares R, Moitinho E, Matilla A et al.: Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002; 36: 1367-73.[PubMed][Crossref]
• 15. Tripathi D, Ferguson JW, Kochar N et al.: Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009; 50: 825-33.[PubMed][Crossref]
• 16. Reiberger T, U lbrich G, Ferlitsch A et al.: Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2012 Dec 18.[WoS]
• 17. Turon F, Casu S, Hernández-Gea V, Garcia-Pagán JC: Variceal and other portal hypertension related bleeding. Best Practice & Research Clinical Gastroenterology 2013 Oct.; Vol: 27, Issue 5: 649-64.[WoS]
• 18. Gonzalez R, Zamora J, Gomez-Camarero J et al.: Meta-analysis: combination endoscopic and drug therapy to prevent varicealrebleeding in cirrhosis. Ann Intern Med 2008 Jul 15; 149(2): 109-22.
• 19. Escorsell À, Bañares R, García-Pagán JC et al.: TIPS versus drug therapy in preventing varicealrebleeding in advanced cirrhosis: A randomized controlled trial. Hepatology 2002, 35: 385-92.[Crossref][PubMed]
• 20. Burroughs AK, Vangeli M: Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Therapy: Randomized Trials for Secondary Prophylaxis of Variceal Bleeding: an Updated Meta-Analysis. Scand J Gastroenterol 2002; Vol. 37, No. 3: 249-52.[Crossref][PubMed]
• 21. Bureau C, Garcia-Pagan JC, Otal P et al.: Improved clinical outcome using polytetrafluoroethylene- coated stents for tips: Results of a randomized study. Gastroenterology, Volume 126, Issue 2, February 2004; 469-75.[Crossref]
• 22. D’Amico G, de Franchis R: Upper digestive bleeding in cirrhosis. Post-therapeuticoutcome and prognosticindicators. Hepatology 2003 Sep; 38(3): 599-612.[Crossref]
• 23. Villanueva C, Colomo A, Bosch A: Transfusion for acute upper gastrointestinal bleeding. N Engl J Med 2013 Apr 4; 368(14): 1362-63.
• 24. Bosch J, Thabut D, Albillos A et al.: Recombinant Factor VIIA (RFVIIA) for active variceal bleeding in patients with advanced cirrhosis: a multi- centre randomized double-blind placebo-controlled trial. J Hepatol 2007; 46 (Suppl. 1): S295.[Crossref]
• 25. Rimola A, Garcia-Tsao G, Navasa M et al.: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000 Jan; 32(1): 142-53.[PubMed][Crossref]
• 26. Fernandez J, Ruiz dA, Gomez C et al.: Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006 Oct; 131(4): 1049-56.
• 27. Wells M, Chande N, Adams P et al.: Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012 Jun; 35(11): 1267-78.[Crossref][WoS][PubMed]
• 28. Augustin S, González A, Genescà J: Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol 2010 Jul 27; Vol. 2 (7): 261-74.[Crossref]
• 29. Nidegger D, Ragot S, Berthelémy P et al.: Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-14.[PubMed][Crossref]
• 30. Dell’Era A, de Franchis R, Iannuzzi F: Best Pract Res Clin Gastroenterol, 2008; Vol. 22 (2): 279-94.
• 31. Ioannou GN, Doust J, Rockey DC: Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003; 17: 53-64.[Crossref][PubMed]
• 32. Walker S, Stiehl A, Raedsch R, Kommerell B: Terlipressininbleeding esophageal varices: a placebo- controlled, double-blind study. Hepatology 1986; 6: 112-15.[PubMed][Crossref]
• 33. Freeman JG, Cobden I, Record CO: Placebocontrolled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 58-60.[Crossref]
• 34. Burroughs AK, McCormick PA, Hughes MD et al.: Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding.[PubMed]
• 35. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388-95.[PubMed]
• 36. Bosch J, Garcia-Pagan JC: Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-56. [Crossref][PubMed]
• 37. Panes J, Teres J, Bosch J i Rodes J: Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Digestive Diseases and Sciences 1988; vol. 33, no. 4: 454-59.[Crossref]
• 38. Cook D, Laine L: Indications, technique, and complications of balloon tamponade for variceal gastrointestinal bleeding. J Intensive Care Med 1992, vol. 7, no. 4: 212-18.
• 39. Biecker E: Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. Hepatology Volume 2013 (2013), Article ID 541836, 20 pages http://dx.doi.org/10.1155/2013/541836.
• 40. Colle I, Wilmer A, Le Moine O et al.: Upper gastrointestinal tract bleeding management: Belgian guidelines for adults and children. Acta Gastroenterol Belg 2011 Mar; Vol. 74 (1): 45-66.[PubMed]
• 41. Sarin SK, Lahoti D, Saxena SP et al.: Prevalence, classification and natural history of gastric varices: a long- term follow-up study in 568 portal hypertension patients. Hepatology 1992; vol. 16, no. 6, pp. 1343-49.
• 42. Bosch J, Abraldes JG, Groszmann R: Current management of portal hypertension. J Hepatology 2003; Suppl, vol. 38, no. 1: S54-S68.
• 43. Spina GP, Arcidiacono R, Bosch J et al.: Gastric endoscopic features in portal hypertension: final Report of a Consensus Conference, Milan, Italy, September 19, 1992, J Hepatology 1994; vol. 21, no. 3, pp. 461-67.
• 44. Yang L, Yuan LJ, Dong R et al.: Two surgical procedures for esophagogastric variceal bleeding in patients with portal hypertension. WJG 2013 Dec 28; Vol. 19 (48): 9418-24.[Crossref]
• 45. Orloff MJ, Orloff MS, Orloff SL et al.: Unshuntable extrahepatic portal hypertension revisited: 43 years’ experience with radical esophagogastrectomy treatment of bleeding esophagogastric varices. Am J Surg 2014 Jan; 207 (1): 46-52.[WoS]
• 46. Liu Y, Li Y, Ma J et al.: A modified Hassab’s operation for portal hypertension: experience with 562 cases. J Surg Res 2013 Nov; Vol. 185 (1): 463-68.[PubMed]
• 47. Thompson RJ, Taylor MA, McKie LD, Diamond T: Sinistral portal hypertension. Ulster Med J Sep 2006; 75(3): 175-77.

Identifiers

DOI

10.2478/pjs-2014-0044